HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
50 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
C9orf72
C9orf72-SMCR8 complex subunit
Chromosome 9 Β· 9p21.2
NCBI Gene: 203228Ensembl: ENSG00000147894.18HGNC: HGNC:28337UniProt: Q96LT7
626PubMed Papers
21Diseases
0Drugs
3Pathogenic Variants
RESEARCH IMPACT
Highly StudiedTrending
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
Atg1/ULK1 kinase complexguanyl-nucleotide exchange factor activityGTPase activator activityprotein bindingamyotrophic lateral sclerosisfrontotemporal dementia and/or amyotrophic lateral sclerosis 1Abnormality of the skeletal systemfrontotemporal dementia with motor neuron disease
✦AI Summary

C9orf72 is a component of the C9orf72-SMCR8 complex that regulates small GTPases, lysosomal integrity, and autophagy 1. The protein functions in multiple cellular processes including autophagy, endocytosis, and GTPase regulation through guanyl-nucleotide exchange factor activity [GO Annotations]. Hexanucleotide repeat expansions in C9orf72 are the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) 2. Disease pathogenesis involves three mechanisms: loss of C9orf72 protein function, toxic gain of function from repeat RNA, and dipeptide repeat proteins from repeat-associated translation 3. C9orf72 haploinsufficiency reduces protein levels and contributes to disease, with SMCR8 stabilizing C9orf72 through protection from proteasomal degradation mediated by the UBR5 E3 ligase 1. Pathological mechanisms include impaired nuclear speckle integrity causing global RNA splicing defects 4, DNA damage, altered phase separation, and nucleocytoplasmic transport defects 5. C9orf72 expansion carriers show shorter survival and more heterogeneous symptoms than non-expansion ALS patients 5. Emerging gene-silencing therapies for C9orf72 ALS underscore the need for improved diagnostic testing access 6.

Sources cited
1
C9orf72-SMCR8 complex regulates small GTPases, lysosomal integrity, and autophagy; SMCR8 stabilizes C9orf72 from proteasomal degradation via UBR5-mediated ubiquitination
PMID: 37317656
2
Hexanucleotide repeat expansions in C9orf72 are the most common cause of ALS and FTD
PMID: 38431841
3
Three main disease mechanisms: loss of C9orf72 function, toxic gain from repeat RNA, and dipeptide repeat proteins from repeat-associated translation
PMID: 30120348
4
C9orf72 repeat RNA disrupts nuclear speckle integrity and causes global RNA splicing defects through sequestration of SRRM2
PMID: 39181135
5
C9orf72 expansion mechanisms include DNA damage, RNA metabolism changes, phase separation alteration, and nucleocytoplasmic transport impairment
PMID: 32860626
6
C9orf72 is the most common ALS gene; gene-silencing therapies for genetic subtypes are emerging
PMID: 38967083
Disease Associationsβ“˜21
amyotrophic lateral sclerosisOpen Targets
0.61Moderate
frontotemporal dementia and/or amyotrophic lateral sclerosis 1Open Targets
0.57Moderate
Abnormality of the skeletal systemOpen Targets
0.37Weak
frontotemporal dementia with motor neuron diseaseOpen Targets
0.37Weak
Huntington disease-like syndrome due to C9ORF72 expansionsOpen Targets
0.37Weak
viral eye infectionOpen Targets
0.32Weak
obesityOpen Targets
0.29Weak
alcohol drinkingOpen Targets
0.26Weak
smoking initiationOpen Targets
0.25Weak
complicationOpen Targets
0.24Weak
type 2 diabetes mellitusOpen Targets
0.23Weak
ovarian dysfunctionOpen Targets
0.23Weak
sporadic amyotrophic lateral sclerosisOpen Targets
0.21Weak
overnutritionOpen Targets
0.21Weak
ectropionOpen Targets
0.19Weak
gastrointestinal diseaseOpen Targets
0.19Weak
Abruptio PlacentaeOpen Targets
0.19Weak
hemolytic anemiaOpen Targets
0.19Weak
vascular diseaseOpen Targets
0.17Weak
smoking cessationOpen Targets
0.17Weak
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1UniProt
Pathogenic Variants3
NC_000009.12:g.27573529_27573534GGCCCC[60_?]Pathogenic
Amyotrophic lateral sclerosis
β˜…β˜†β˜†β˜†2022
NG_031977.1:g.(5321_5338)ins(60_?)Pathogenic
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
β˜†β˜†β˜†β˜†2014
NM_001256054.1(C9orf72):c.-45+163GGGGCC[>24]Pathogenic
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
β˜†β˜†β˜†β˜†2013
View on ClinVar β†—
Related Genes
ARF1Protein interaction100%RAB8AProtein interaction100%RAB39BProtein interaction100%LAMTOR4Protein interaction100%HNRNPA1Protein interaction100%ULK1Protein interaction98%
Tissue Expression6 tissues
Ovary
100%
Bone Marrow
98%
Lung
90%
Brain
72%
Heart
42%
Liver
34%
Gene Interaction Network
Click a node to explore
C9orf72ARF1RAB8ARAB39BLAMTOR4HNRNPA1ULK1
PROTEIN STRUCTURE
Preparing viewer…
PDB6LT0 Β· 3.20 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.99LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.62 [0.40–0.99]
RankingsWhere C9orf72 stands among ~20K protein-coding genes
  • #366of 20,598
    Most Researched626 Β· top 5%
  • #3,892of 5,498
    Most Pathogenic Variants3
  • #9,480of 17,882
    Most Constrained (LOEUF)0.99
Genes detectedC9orf72
Sources retrieved50 papers
Response timeβ€”
πŸ“„ Sources
50β–Ό
1
C9orf72-mediated ALS and FTD: multiple pathways to disease.
PMID: 30120348
Nat Rev Neurol Β· 2018
1.00
2
The genetics of amyotrophic lateral sclerosis.
PMID: 38967083
Curr Opin Neurol Β· 2024
0.90
3
Origin and cell type specificity of mitochondrial DNA mutations in
PMID: 40053600
Sci Adv Β· 2025
0.88
4
Amyotrophic lateral sclerosis.
PMID: 29045369
Nature Β· 2017
0.82
5
Chorea.
PMID: 27495204
Continuum (Minneap Minn) Β· 2016
0.80